JAK2 V617F is common in patients with BCR/ABL1 negative MPNs and is rare in patients with CML but not in those with lymphoid neoplasms, reactive myelo-proliferative disorders or normals [10,11]. Here, JAK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.